BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 25759969)

  • 1. Advanced Cirrhosis Combined with Portal Vein Thrombosis: A Randomized Trial of TIPS versus Endoscopic Band Ligation Plus Propranolol for the Prevention of Recurrent Esophageal Variceal Bleeding.
    Luo X; Wang Z; Tsauo J; Zhou B; Zhang H; Li X
    Radiology; 2015 Jul; 276(1):286-93. PubMed ID: 25759969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial.
    Lv Y; Qi X; He C; Wang Z; Yin Z; Niu J; Guo W; Bai W; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Liu H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Xia J; Cai H; Yang Z; Wu K; Fan D; Han G;
    Gut; 2018 Dec; 67(12):2156-2168. PubMed ID: 28970291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial.
    Sauer P; Hansmann J; Richter GM; Stremmel W; Stiehl A
    Endoscopy; 2002 Sep; 34(9):690-7. PubMed ID: 12195325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early use of TIPS in patients with cirrhosis and variceal bleeding.
    García-Pagán JC; Caca K; Bureau C; Laleman W; Appenrodt B; Luca A; Abraldes JG; Nevens F; Vinel JP; Mössner J; Bosch J;
    N Engl J Med; 2010 Jun; 362(25):2370-9. PubMed ID: 20573925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transjugular intrahepatic portosystemic shunt prevents rebleeding in cirrhotic patients having cavernous transformation of the portal vein without improving their survival.
    Li LN; Sun XY; Wang GC; Tian XG; Zhang MY; Jiang KT; Zhang CQ
    J Dig Dis; 2019 Feb; 20(2):89-96. PubMed ID: 30629804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol associated with endoscopic band ligation reduces recurrence of esophageal varices for primary prophylaxis of variceal bleeding: a randomized-controlled trial.
    Bonilha DQ; Lenz L; Correia LM; Rodrigues RA; de Paulo GA; Ferrari AP; Della Libera E
    Eur J Gastroenterol Hepatol; 2015 Jan; 27(1):84-90. PubMed ID: 25397691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
    Sauerbruch T; Mengel M; Dollinger M; Zipprich A; Rössle M; Panther E; Wiest R; Caca K; Hoffmeister A; Lutz H; Schoo R; Lorenzen H; Trebicka J; Appenrodt B; Schepke M; Fimmers R;
    Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-Diameter Transjugular Intrahepatic Portosystemic Shunt versus Endoscopic Variceal Ligation Plus Propranolol for Variceal Rebleeding in Advanced Cirrhosis.
    Wang X; Liu G; Wu J; Xiao X; Yan Y; Guo Y; Yang J; Li X; He Y; Yang L; Luo X
    Radiology; 2023 Aug; 308(2):e223201. PubMed ID: 37606572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of transjugular intrahepatic portosystemic shunts vs endoscopic band ligation plus propranolol in patients with cirrhosis with portal vein thrombosis: a systematic review and meta-analysis.
    Berengy MS; Abd El-Hamid Hassan EM; Ibrahim AH; Mohamed EF
    J Gastrointest Surg; 2024 Mar; 28(3):316-326. PubMed ID: 38445926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.
    Lv Y; Yang Z; Liu L; Li K; He C; Wang Z; Bai W; Guo W; Yu T; Yuan X; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Niu J; Cai H; Xia J; Yin Z; Wu K; Fan D; Han G;
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):587-598. PubMed ID: 31153882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β-blocker for prevention of variceal rebleeding.
    Holster IL; Tjwa ET; Moelker A; Wils A; Hansen BE; Vermeijden JR; Scholten P; van Hoek B; Nicolai JJ; Kuipers EJ; Pattynama PM; van Buuren HR
    Hepatology; 2016 Feb; 63(2):581-9. PubMed ID: 26517576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome comparison between TIPS and EBL in patients with cirrhosis and portal vein thrombosis.
    Wang Z; Zhao H; Wang X; Zhang H; Jiang M; Tsauo J; Luo X; Yang L; Li X
    Abdom Imaging; 2015 Aug; 40(6):1813-20. PubMed ID: 25504374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second prophylaxis of variceal bleeding in cirrhotic patients with a high HVPG.
    Zhang M; Wang G; Zhao L; Wu Z; Zhang W; Zhang C
    Scand J Gastroenterol; 2016 Dec; 51(12):1502-1506. PubMed ID: 27379704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization.
    Chen S; Li X; Wei B; Tong H; Zhang MG; Huang ZY; Cao JW; Tang CW
    Radiology; 2013 Sep; 268(3):900-6. PubMed ID: 23657891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding.
    Rössle M; Deibert P; Haag K; Ochs A; Olschewski M; Siegerstetter V; Hauenstein KH; Geiger R; Stiepak C; Keller W; Blum HE
    Lancet; 1997 Apr; 349(9058):1043-9. PubMed ID: 9107241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy for the prevention of recurrent esophageal variceal bleeding.
    Russo MW; Zacks SL; Sandler RS; Brown RS
    Hepatology; 2000 Feb; 31(2):358-63. PubMed ID: 10655258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
    Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M;
    Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary prophylaxis for esophageal variceal bleeding.
    Albillos A; Tejedor M
    Clin Liver Dis; 2014 May; 18(2):359-70. PubMed ID: 24679500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of transjugular intrahepatic portosystemic with endoscopic treatment plus anticoagulation for esophageal variceal bleeding and portal vein thrombosis in liver cirrhosis.
    Wu W; Zhang H; Zeng Z; Wang X; Kong D
    Scand J Gastroenterol; 2022 Dec; 57(12):1494-1502. PubMed ID: 35802771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
    Li ZP; Wang SS; Wang GC; Huang GJ; Cao JQ; Zhang CQ
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):517-523. PubMed ID: 30262421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.